Cure My Disease

Don't miss your cure!

 Log in / Sign up

Exercise program aims to reverse artery damage in heart patients

NCT ID NCT06579807

Recruiting now Disease control Sponsor: Instituto Nacional de Cardiologia de Laranjeiras Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a 12-week supervised exercise program can improve artery health and reduce inflammation in people with coronary artery disease. Fifty patients aged 40-70 will do aerobic, resistance, and flexibility exercises three times a week. Researchers will measure artery thickness, blood vessel function, and blood markers of inflammation before and after the program.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
exercise training (aerobic, resistance, and flexibility exercises)
What this could lead to
If successful, this could show that a structured exercise program improves artery health and reduces inflammation in people with coronary artery disease.
What could go wrong
This is a small, early-stage study with only 50 participants, so results may not apply to everyone. The exercise program is supervised and generally safe, but there is a small risk of injury or cardiac events during exercise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerosis coronary artery disorder Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATHEROSCLEROSIS CORONARY ARTERY DISEASE

Contacts and locations

Locations

  • Rio de Janeiro State University

    RECRUITING

    Rio de Janeiro, Rio de Janeiro, 20550-900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.